MX2017013360A - Métodos para tratar el cáncer. - Google Patents
Métodos para tratar el cáncer.Info
- Publication number
- MX2017013360A MX2017013360A MX2017013360A MX2017013360A MX2017013360A MX 2017013360 A MX2017013360 A MX 2017013360A MX 2017013360 A MX2017013360 A MX 2017013360A MX 2017013360 A MX2017013360 A MX 2017013360A MX 2017013360 A MX2017013360 A MX 2017013360A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- treating cancer
- compound
- kits
- administering
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 229930012538 Paclitaxel Natural products 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960001592 paclitaxel Drugs 0.000 abstract 1
- -1 paclitaxel compound Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562149349P | 2015-04-17 | 2015-04-17 | |
| US201662280947P | 2016-01-20 | 2016-01-20 | |
| PCT/US2016/028177 WO2016168856A1 (en) | 2015-04-17 | 2016-04-18 | Methods for treating cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2017013360A true MX2017013360A (es) | 2018-08-01 |
Family
ID=55854799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017013360A MX2017013360A (es) | 2015-04-17 | 2016-04-18 | Métodos para tratar el cáncer. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20180085341A1 (enExample) |
| EP (1) | EP3283069A1 (enExample) |
| JP (1) | JP2018511643A (enExample) |
| KR (1) | KR20180006918A (enExample) |
| CN (1) | CN107666906A (enExample) |
| AU (1) | AU2016247319A1 (enExample) |
| BR (1) | BR112017022281A2 (enExample) |
| CA (1) | CA2983010A1 (enExample) |
| EA (1) | EA201792287A1 (enExample) |
| HK (1) | HK1250944A1 (enExample) |
| IL (1) | IL255022A0 (enExample) |
| MX (1) | MX2017013360A (enExample) |
| PH (1) | PH12017501879A1 (enExample) |
| SG (2) | SG11201708504XA (enExample) |
| TW (1) | TW201713327A (enExample) |
| WO (1) | WO2016168856A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2190429B1 (en) | 2007-09-10 | 2016-04-20 | Boston Biomedical, Inc. | A novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitors |
| US20160030384A1 (en) | 2013-04-09 | 2016-02-04 | Boston Biomedical, Inc. | 2-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancer |
| WO2017132049A1 (en) * | 2016-01-20 | 2017-08-03 | Boston Biomedical, Inc. | Methods for treating cancer |
| CA3045306A1 (en) | 2016-11-29 | 2018-06-07 | Boston Biomedical, Inc. | Naphthofuran derivatives, preparation, and methods of use thereof |
| JP2020520923A (ja) | 2017-05-17 | 2020-07-16 | ボストン バイオメディカル， インコーポレイテッド | がんを処置するための方法 |
| JP7399079B2 (ja) * | 2017-09-05 | 2023-12-15 | エピザイム，インコーポレイティド | 癌を処置するための併用療法 |
| MX2021004151A (es) * | 2018-10-12 | 2021-09-08 | 1Globe Biomedical Co Ltd | Nueva solución de combinación para el tratamiento contra cáncer refractario a la quimioterapia. |
| EP3705893A1 (en) * | 2019-03-05 | 2020-09-09 | Humanitas Mirasole S.p.A. | Methods to assess the risk of being affected by prostate cancer |
| SG11202110338XA (en) * | 2019-03-27 | 2021-10-28 | Singapore Health Serv Pte Ltd | Biomarker with therapeutic implications for peritoneal carcinomatosis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2190429B1 (en) | 2007-09-10 | 2016-04-20 | Boston Biomedical, Inc. | A novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitors |
| DK2547205T3 (da) | 2010-03-19 | 2024-05-27 | 1Globe Biomedical Co Ltd | Hidtil ukendte fremgangsmåder til målretning mod cancerstamceller |
| NZ602328A (en) | 2010-03-19 | 2014-11-28 | Boston Biomedical Inc | Novel compounds and compositions for targeting cancer stem cells |
| CN103402993A (zh) | 2011-03-04 | 2013-11-20 | 舟山海中洲新生药业有限公司 | 用于疾病治疗的4，9-二羟基-萘并[2,3-b] 呋喃新型酯 |
| US8977803B2 (en) | 2011-11-21 | 2015-03-10 | Western Digital Technologies, Inc. | Disk drive data caching using a multi-tiered memory |
| WO2013166618A1 (en) * | 2012-05-08 | 2013-11-14 | Zhoushan Haizhongzhou Xinsheng Pharmaceuticals Co., Ltd. | PRODRUGS OF 4,9-DIHYDROXY-NAPHTHO[2,3-b]FURANS FOR CIRCUMVENTING CANCER MULTIDRUG RESISTANCE |
| US20160030384A1 (en) * | 2013-04-09 | 2016-02-04 | Boston Biomedical, Inc. | 2-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancer |
| WO2017132049A1 (en) * | 2016-01-20 | 2017-08-03 | Boston Biomedical, Inc. | Methods for treating cancer |
-
2016
- 2016-04-18 JP JP2017554403A patent/JP2018511643A/ja active Pending
- 2016-04-18 BR BR112017022281A patent/BR112017022281A2/pt not_active Application Discontinuation
- 2016-04-18 WO PCT/US2016/028177 patent/WO2016168856A1/en not_active Ceased
- 2016-04-18 EA EA201792287A patent/EA201792287A1/ru unknown
- 2016-04-18 SG SG11201708504XA patent/SG11201708504XA/en unknown
- 2016-04-18 US US15/566,919 patent/US20180085341A1/en not_active Abandoned
- 2016-04-18 HK HK18110438.9A patent/HK1250944A1/zh unknown
- 2016-04-18 CN CN201680032355.6A patent/CN107666906A/zh active Pending
- 2016-04-18 AU AU2016247319A patent/AU2016247319A1/en not_active Abandoned
- 2016-04-18 CA CA2983010A patent/CA2983010A1/en not_active Abandoned
- 2016-04-18 TW TW105112097A patent/TW201713327A/zh unknown
- 2016-04-18 KR KR1020177033135A patent/KR20180006918A/ko not_active Withdrawn
- 2016-04-18 MX MX2017013360A patent/MX2017013360A/es unknown
- 2016-04-18 SG SG10201900564WA patent/SG10201900564WA/en unknown
- 2016-04-18 EP EP16723854.2A patent/EP3283069A1/en not_active Withdrawn
-
2017
- 2017-10-15 IL IL255022A patent/IL255022A0/en unknown
- 2017-10-18 PH PH12017501879A patent/PH12017501879A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201708504XA (en) | 2017-11-29 |
| CA2983010A1 (en) | 2016-10-20 |
| TW201713327A (zh) | 2017-04-16 |
| IL255022A0 (en) | 2017-12-31 |
| HK1250944A1 (zh) | 2019-01-18 |
| KR20180006918A (ko) | 2018-01-19 |
| CN107666906A (zh) | 2018-02-06 |
| AU2016247319A1 (en) | 2017-11-02 |
| EA201792287A1 (ru) | 2018-03-30 |
| WO2016168856A1 (en) | 2016-10-20 |
| SG10201900564WA (en) | 2019-02-27 |
| PH12017501879A1 (en) | 2018-03-05 |
| BR112017022281A2 (pt) | 2018-07-10 |
| US20180085341A1 (en) | 2018-03-29 |
| JP2018511643A (ja) | 2018-04-26 |
| EP3283069A1 (en) | 2018-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017501879A1 (en) | Methods for treating cancer | |
| PH12020550901A1 (en) | Macrocyclic compounds for treating disease | |
| MY198613A (en) | Nitrobenzyl derivatives of anti-cancer agents | |
| EP4302835A3 (en) | Methods of treating ovarian cancer | |
| MX394380B (es) | Compuestos dinucleótidos cíclicos para eltratamiento de cáncer | |
| MX379270B (es) | Composiciones que comprenden cepas bacterianas. | |
| IL253979A0 (en) | Methods, preparations and kits for cancer treatment | |
| HK1258098A1 (zh) | 治疗癌症的方法 | |
| PH12016500330B1 (en) | Certain chemical entities, compositions, and methods | |
| MX2019001471A (es) | Anticuerpos anti-siglec-7 para el tratamiento del cancer. | |
| MX2021006326A (es) | Inhibidores de pcna. | |
| MX2018000715A (es) | Metodos para tratar cancer usando apilimod. | |
| MX2016009663A (es) | Derivados de icariina. | |
| JOP20200244A1 (ar) | مشتقات بلاديينوليد كعوامل تستهدف جسيمات الوصل لعلاج السرطان | |
| IL268163A (en) | Methods, compositions, and kits for treatment of cancer | |
| MX379271B (es) | Compuestos desestabilizadores de microtubulina para usarse en el tratamiento del cáncer. | |
| MX382904B (es) | Combinaciones de fármacos para tratar mieloma múltiple. | |
| TW201613587A (en) | Medical treatments based on anamorelin | |
| LT3534885T (lt) | Farneziltransferazės inhibitoriai, skirti naudoti vėžio gydymui | |
| MX388409B (es) | Composiciones y metodos para tratar canceres. | |
| PH12017501880A1 (en) | Methods for treating cancer | |
| MX382092B (es) | Compuestos heterocíclicos para el tratamiento de enfermedades. | |
| MX2015013021A (es) | 5-bromo-indirrubinas. | |
| EP3487999A4 (en) | METHODS OF TREATING CANCER | |
| MX390571B (es) | Metodos para tratamiento de cancer de ovario. |